<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27135915</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2567</ISSN><JournalIssue CitedMedium="Internet"><Volume>148</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Immunology</Title><ISOAbbreviation>Immunology</ISOAbbreviation></Journal><ArticleTitle>Distinct expression of interferon-induced protein with tetratricopeptide repeats (IFIT) 1/2/3 and other antiviral genes between subsets of dendritic cells induced by dengue virus 2 infection.</ArticleTitle><Pagination><StartPage>363</StartPage><EndPage>376</EndPage><MedlinePgn>363-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/imm.12615</ELocationID><Abstract><AbstractText>Dengue virus (DENV) infection is an emerging public health hazard threatening inhabitants of the tropics and sub-tropics. Dendritic cells (DCs) are one of the major targets of DENV and the initiators of the innate immune response against the virus. However, current in&#xa0;vitro research on the DENV-DC interaction is hampered by the low availability of ex&#xa0;vivo DCs and donor variation. In the current study, we attempted to develop a novel in&#xa0;vitro DC model using immature DCs derived from the myeloid leukaemia cell line MUTZ-3 (IMDCs) to investigate the DENV-DC interaction. The IMDCs morphologically and phenotypically resembled human immature monocyte-derived dendritic cells (IMMoDCs). However, the permissiveness of IMDCs to DENV2 was lower than that of IMMoDCs. RT-PCR arrays showed that a group of type I interferon (IFN) -inducible genes, especially IFIT1, IFITM1, and IFI27, were significantly up-regulated in IMMoDCs but not in IMDCs after DENV2 infection. Further investigation revealed that IFIT genes were spontaneously expressed at both transcriptional and protein levels in the naive IMDCs but not in the naive IMMoDCs. It is possible that the poor permissiveness of IMDCs to DENV2 was a result of the high basal levels of IFIT proteins. We conclude that the IMDC model, although less permissive to DENV2, is a useful platform for studying the suppression mechanism of DENV2 and we expand the knowledge of cellular factors that modulate DENV2 infection in the human body.</AbstractText><CopyrightInformation>&#xa9; 2016 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jingshu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HKU-Pasteur Research Pole, School of Public Health, The University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sze</LastName><ForeName>Daniel Man-Yuen</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Health and Biomedical Sciences, Royal Melbourne Institute of Technology (RMIT) University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yung</LastName><ForeName>Benjamin Yat-Ming</ForeName><Initials>BY</Initials><AffiliationInfo><Affiliation>Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Petrus</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Molecular Regulation and Bioinformatics Laboratory, Department of Public Health and Parasitology, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Sciences, Chang Gung University, Kwei-San, Tao-Yuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wei-June</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Sciences, Chang Gung University, Kwei-San, Tao-Yuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health and Parasitology, College of Medicine, Chang Gung University, Kwei-San, Tao-Yuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Kwok-Hung</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>Polly Hang-Mei</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>NM_000395</AccessionNumber><AccessionNumber>NM_000566</AccessionNumber><AccessionNumber>NM_001548</AccessionNumber><AccessionNumber>NM_001549</AccessionNumber><AccessionNumber>NM_001565</AccessionNumber><AccessionNumber>NM_001572</AccessionNumber><AccessionNumber>NM_001992</AccessionNumber><AccessionNumber>NM_002038</AccessionNumber><AccessionNumber>NM_002053</AccessionNumber><AccessionNumber>NM_002198</AccessionNumber><AccessionNumber>NM_002199</AccessionNumber><AccessionNumber>NM_002201</AccessionNumber><AccessionNumber>NM_002463</AccessionNumber><AccessionNumber>NM_002534</AccessionNumber><AccessionNumber>NM_002535</AccessionNumber><AccessionNumber>NM_002744</AccessionNumber><AccessionNumber>NM_002759</AccessionNumber><AccessionNumber>NM_002838</AccessionNumber><AccessionNumber>NM_003641</AccessionNumber><AccessionNumber>NM_003877</AccessionNumber><AccessionNumber>NM_004219</AccessionNumber><AccessionNumber>NM_004688</AccessionNumber><AccessionNumber>NM_005101</AccessionNumber><AccessionNumber>NM_005419</AccessionNumber><AccessionNumber>NM_005531</AccessionNumber><AccessionNumber>NM_005532</AccessionNumber><AccessionNumber>NM_005902</AccessionNumber><AccessionNumber>NM_006084</AccessionNumber><AccessionNumber>NM_006435</AccessionNumber><AccessionNumber>NM_007315</AccessionNumber><AccessionNumber>NM_018191</AccessionNumber><AccessionNumber>NM_022168</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Immunology</MedlineTA><NlmUniqueID>0374672</NlmUniqueID><ISSNLinking>0019-2805</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000943">Antigens, Differentiation</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C406887">IFI27 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C484290">IFIT1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C062010">leu-13 antigen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000943" MajorTopicYN="N">Antigens, Differentiation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MUTZ-3</Keyword><Keyword MajorTopicYN="N">dendritic cells</Keyword><Keyword MajorTopicYN="N">dengue virus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27135915</ArticleId><ArticleId IdType="pmc">PMC4948034</ArticleId><ArticleId IdType="doi">10.1111/imm.12615</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Halstead SB. Dengue. Lancet 2007; 370:1644&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">17993365</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Dengue and severe dengue. Geneva: World Health Organization, 2012.</Citation></Reference><Reference><Citation>Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 2009; 22:564&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2772360</ArticleId><ArticleId IdType="pubmed">19822889</ArticleId></ArticleIdList></Reference><Reference><Citation>Bente DA, Rico&#x2010;Hesse R. Models of dengue virus infection. Drug Discov Today Dis Models 2006; 3:97&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1949394</ArticleId><ArticleId IdType="pubmed">18087566</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark KB, Hsiao HM, Noisakran S, Tsai JJ, Perng GC. Role of microparticles in dengue virus infection and its impact on medical intervention strategies. Yale J Biol Med 2012; 85:3&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3313537</ArticleId><ArticleId IdType="pubmed">22461739</ArticleId></ArticleIdList></Reference><Reference><Citation>Belz G., Mount A and Masson F. Dendritic cells in viral infections. Handb Exp Pharmacol 2009; 188:51&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">19031021</ArticleId></ArticleIdList></Reference><Reference><Citation>Libraty DH, Pichyangkul S, Ajariyakhajorn C, Endy TP, Ennis FA. Human dendritic cells are activated by dengue virus infection: enhancement by &#x3b3; interferon and implications for disease pathogenesis. J Virol 2001; 75:3501&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC114841</ArticleId><ArticleId IdType="pubmed">11264339</ArticleId></ArticleIdList></Reference><Reference><Citation>Marovich M, Grouard&#x2010;Vogel G, Louder M, Eller M, Sun W, Wu SJ et&#xa0;al Human dendritic cells as targets of dengue virus infection. J Investig Dermatol Symp Proc 2001; 6:219&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">11924831</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu SJ, Grouard&#x2010;Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R et&#xa0;al Human skin Langerhans cells are targets of dengue virus infection. Nat Med 2000; 6:816&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">10888933</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun P, Fernandez S, Marovich MA, Palmer DR, Celluzzi CM, Boonnak K et&#xa0;al Functional characterization of ex&#xa0;vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus. Virology 2009; 383:207&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">19013627</ArticleId></ArticleIdList></Reference><Reference><Citation>Della Chiesa M, Sivori S, Castriconi R, Marcenaro E, Moretta A. Pathogen&#x2010;induced private conversations between natural killer and dendritic cells. Trends Microbiol 2005; 13:128&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">15737731</ArticleId></ArticleIdList></Reference><Reference><Citation>Hershkovitz O, Rosental B, Rosenberg LA, Navarro&#x2010;Sanchez ME, Jivov S, Zilka A et&#xa0;al NKp44 receptor mediates interaction of the envelope glycoproteins from the west Nile and dengue viruses with NK cells. J Immunol 2009; 183:2610&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2768489</ArticleId><ArticleId IdType="pubmed">19635919</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson LI, Cirkic E, Hellman P, Eriksson H. Myeloid blood dendritic cells and monocyte&#x2010;derived dendritic cells differ in their endocytosing capability. Hum Immunol 2012; 73:1073&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">22902393</ArticleId></ArticleIdList></Reference><Reference><Citation>van Helden SF, van Leeuwen FN, Figdor CG. Human and murine model cell lines for dendritic cell biology evaluated. Immunol Lett 2008; 117:191&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">18384885</ArticleId></ArticleIdList></Reference><Reference><Citation>Masterson AJ, Sombroek CC, De Gruijl TD, Graus YM, van der Vliet HJ, Lougheed SM et&#xa0;al MUTZ&#x2010;3, a human cell line model for the cytokine&#x2010;induced differentiation of dendritic cells from CD34+ precursors. Blood 2002; 100:701&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">12091369</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson K, Lindstedt M, Borrebaeck CA. Functional and transcriptional profiling of MUTZ&#x2010;3, a myeloid cell line acting as a model for dendritic cells. Immunology 2006; 117:156&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1782214</ArticleId><ArticleId IdType="pubmed">16423051</ArticleId></ArticleIdList></Reference><Reference><Citation>Santegoets SJ, van den Eertwegh AJ, van de Loosdrecht AA, Scheper RJ, de Gruijl TD. Human dendritic cell line models for DC differentiation and clinical DC vaccination studies. J Leukoc Biol 2008; 84:1364&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">18664532</ArticleId></ArticleIdList></Reference><Reference><Citation>Santegoets SJ, Schreurs MW, Masterson AJ, Liu YP, Goletz S, Baumeister H et&#xa0;al In vitro priming of tumor&#x2010;specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ&#x2010;3 cell line. Cancer Immunol Immunother 2006; 55:1480&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">16468034</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Loosdrecht AA, van den Ancker W, Houtenbos I, Ossenkoppele GJ, Westers&#xa0;TM . Dendritic cell&#x2010;based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications. Handb Exp Pharmacol 2009; 000:319&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">19031033</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen WJ, Chen TH, Tang P, Yang CF, Kao LH, Lo YP et&#xa0;al Antioxidant defense is one of the mechanisms by which mosquito cells survive dengue 2 viral infection. Virology 2011; 410:410&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21216424</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CY, Hu HP, King CC, Wang WK. Incorporation of dengue virus replicon into virus&#x2010;like particles by a cell line stably expressing precursor membrane and envelope proteins of dengue virus type 2. J Biomed Sci 2008; 15:15&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">17768670</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein&#x2010;dye binding. Anal Biochem 1976; 72:248&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">942051</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasaiyaah J, Noursadeghi M, Kellam P, Chain B. Transcriptional and functional defects of dendritic cells derived from the MUTZ&#x2010;3 leukaemia line. Immunology 2009; 127:429&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2712111</ArticleId><ArticleId IdType="pubmed">19538250</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichlmair A, Lassnig C, Eberle CA, Gorna MW, Baumann CL, Burkard TR et&#xa0;al IFIT1 is an antiviral protein that recognizes 5 &#x2018;&#x2010;triphosphate RNA. Nat Immunol 2011; 12:624&#x2013;U177.</Citation><ArticleIdList><ArticleId IdType="pubmed">21642987</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P, Sweeney TR, Skabkin MA, Skabkina OV, Hellen CU, Pestova TV. Inhibition of translation by IFIT family members is determined by their ability to interact selectively with the 5&#x2032;&#x2010;terminal regions of cap0&#x2010;, cap1&#x2010; and 5&#x2032;ppp&#x2010; mRNAs. Nucleic Acids Res 2014; 42:3228&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3950709</ArticleId><ArticleId IdType="pubmed">24371270</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas YM, Pichlmair A, Gorna MW, Superti&#x2010;Furga G, Nagar B. Structural basis for viral 5&#x2032;&#x2010;PPP&#x2010;RNA recognition by human IFIT proteins. Nature 2013; 494:60&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4931921</ArticleId><ArticleId IdType="pubmed">23334420</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura T, Katoh H, Kayama H, Saiga H, Okuyama M, Okamoto T et&#xa0;al Ifit1 inhibits Japanese encephalitis virus replication through binding to 5&#x2032; capped 2&#x2032;&#x2010;O unmethylated RNA. J Virol 2013; 87:9997&#x2013;10003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3754022</ArticleId><ArticleId IdType="pubmed">23824812</ArticleId></ArticleIdList></Reference><Reference><Citation>Habjan M, Hubel P, Lacerda L, Benda C, Holze C, Eberl CH et&#xa0;al Sequestration by IFIT1 impairs translation of 2&#x2032;O&#x2010;unmethylated capped RNA. PLoS Pathog 2013; 9:e1003663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3789756</ArticleId><ArticleId IdType="pubmed">24098121</ArticleId></ArticleIdList></Reference><Reference><Citation>Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, Errett J et&#xa0;al 2&#x2032;&#x2010;O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 2010; 468:452&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3058805</ArticleId><ArticleId IdType="pubmed">21085181</ArticleId></ArticleIdList></Reference><Reference><Citation>Fensterl V, Sen GC. Interferon&#x2010;induced Ifit proteins: their role in viral pathogenesis. J Virol 2015; 89:2462&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4325746</ArticleId><ArticleId IdType="pubmed">25428874</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueno H, Schmitt N, Klechevsky E, Pedroza&#x2010;Gonzalez A, Matsui T, Zurawski G et&#xa0;al Harnessing human dendritic cell subsets for medicine. Immunol Rev 2010; 234:199&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2847489</ArticleId><ArticleId IdType="pubmed">20193020</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei HY, Yeh TM, Liu HS, Lin YS, Chen SH, Liu CC. Immunopathogenesis of dengue virus infection. J Biomed Sci 2001; 8:377&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">11549879</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer DR, Sun P, Celluzzi C, Bisbing J, Pang S, Sun W et&#xa0;al Differential effects of dengue virus on infected and bystander dendritic cells. J Virol 2005; 79:2432&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC546567</ArticleId><ArticleId IdType="pubmed">15681444</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina FA, Torres&#x2010;Malave G, Chase AJ, Santiago GA, Medina JF, Santiago LM et&#xa0;al Differences in type I interferon signaling antagonism by dengue viruses in human and non&#x2010;human primate cell lines. PLoS Negl Trop Dis 2015; 9:e0003468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4359095</ArticleId><ArticleId IdType="pubmed">25768016</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz&#x2010;Jordan JL, Sanchez&#x2010;Burgos GG, Laurent&#x2010;Rolle M, Garcia&#x2010;Sastre A. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A 2003; 100:14333&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC283592</ArticleId><ArticleId IdType="pubmed">14612562</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalrymple N. A., Cimica V and Mackow E.R.. Dengue virus NS proteins inhibit RIG&#x2010;I/MAVS signaling by blocking TBK1/IRF3 phosphorylation: dengue virus serotype 1 NS4A Is a unique interferon&#x2010;regulating virulence determinant. MBio 2015; 6:e00553&#x2013;00515.z</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4436066</ArticleId><ArticleId IdType="pubmed">25968648</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashour J, Laurent&#x2010;Rolle M, Shi PY, Garcia&#x2010;Sastre A. NS5 of dengue virus mediates STAT2 binding and degradation. J Virol 2009; 83:5408&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2681973</ArticleId><ArticleId IdType="pubmed">19279106</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison J, Laurent&#x2010;Rolle M, Maestre AM, Rajsbaum R, Pisanelli G, Simon V et&#xa0;al Dengue virus co&#x2010;opts UBR4 to degrade STAT2 and antagonize type I interferon signaling. PLoS Pathog 2013; 9:e1003265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3610674</ArticleId><ArticleId IdType="pubmed">23555265</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez&#x2010;Madoz JR, Bernal&#x2010;Rubio D, Kaminski D, Boyd K, Fernandez&#x2010;Sesma A. Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol 2010; 84:4845&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2863727</ArticleId><ArticleId IdType="pubmed">20164230</ArticleId></ArticleIdList></Reference><Reference><Citation>De Weer A, Poppe B, Vergult S, Van Vlierberghe P, Petrick M, De Bock R et&#xa0;al Identification of two critically deleted regions within chromosome segment 7q35&#x2010;q36 in EVI1 deregulated myeloid leukemia cell lines. PLoS One 2010; 5:e8676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2800774</ArticleId><ArticleId IdType="pubmed">20084277</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D, Holko M, Sadler AJ, Scott B, Higashiyama S, Berkofsky&#x2010;Fessler W et&#xa0;al Promyelocytic leukemia zinc finger protein regulates interferon&#x2010;mediated innate immunity. Immunity 2009; 30:802&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2711215</ArticleId><ArticleId IdType="pubmed">19523849</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesri EA, Feitelson MA, Munger K. Human viral oncogenesis: a cancer hallmarks analysis. Cell Host Microbe 2014; 15:266&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3992243</ArticleId><ArticleId IdType="pubmed">24629334</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>